Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: Identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis

被引:88
作者
Albig A.R. [1 ]
Roy T.G. [1 ]
Becenti D.J. [1 ]
Schiemann W.P. [1 ]
机构
[1] Department of Pharmacology, University of Colorado Health Sciences Center, RC1 South Tower, Aurora, CO 80045
基金
美国国家卫生研究院;
关键词
Angiogenesis; Lumican; MAGP-2; Microarray analyses; Microenvironment remodeling; Stroma;
D O I
10.1007/s10456-007-9075-z
中图分类号
学科分类号
摘要
Remodeling of vascular microenvironments during normal and tumor-induced angiogenesis is an important, yet poorly understood mechanism by which endothelial cells (ECs) contribute to the activation or resolution of angiogenesis. We used microarray analyses to monitor changes in the transcriptome of ECs undergoing angiogenesis when cultured onto Matrigel matrices. This strategy identified 308 genes whose expression in ECs was altered at least 3-fold by angiogenesis, of which 63 genes were found to encode for secretory proteins. In vitro assays that modeled key steps in the angiogenic process showed that several identified genes possessed pro- or anti-angiogenic activities (e.g., SMOC-2, secreted modular calcium-binding protein-2; CRELD-2, cysteine-rich with EGF-like domains-1; MAGP-2, microfibril-associated glycoprotein-2; lumican; and ECM-1, extracellular matrix protein-1). In particular, MAGP-2 expression potentiated EC proliferation and p38 MAPK activation stimulated by the pro-angiogenic factors, basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF); it also stimulated EC invasion and angiogenic sprouting, and more importantly, promoted the development and infiltration of vessels into Matrigel plugs implanted into genetically normal mice. Conversely, lumican inhibited EC activation of p38 MAPK, as well as their invasion, angiogenic sprouting, and vessel formation in mice. Collectively, our findings provide new insights into how EC stromal remodeling regulates angiogenesis activation and resolution, as well as identify two novel EC-secreted stromal proteins that modulate angiogenesis both in vitro and in vivo. © 2007 Springer Science + Business Media B.V.
引用
收藏
页码:197 / 216
页数:19
相关论文
共 67 条
[1]  
Folkman J., Shing Y., Angiogenesis, J Biol Chem, 267, pp. 10931-10934, (1992)
[2]  
Carmeliet P., Jain R.K., Angiogenesis in cancer and other diseases, Nature, 407, pp. 249-257, (2000)
[3]  
Bergers G., Benjamin L.E., Tumorigenesis and the angiogenic switch, Nat Rev Cancer, 3, pp. 401-410, (2003)
[4]  
Hanahan D., Folkman J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, pp. 353-364, (1996)
[5]  
Stupack D.G., Cheresh D.A., ECM remodeling regulates angiogenesis: Endothelial integrins look for new ligands, Sci STKE, 2002, (2002)
[6]  
Liotta L.A., Kohn E.C., The microenvironment of the tumor-host interface, Nature, 411, pp. 375-379, (2001)
[7]  
Joyce J.A., Therapeutic targeting of the tumor microenvironment, Cancer Cell, 7, pp. 513-520, (2005)
[8]  
Heissig B., Hattori K., Friedrich M., Rafii S., Werb Z., Angiogenesis: Vascular remodeling of the extracellular matrix involves metalloproteinases, Curr Opin Hematol, 10, pp. 136-141, (2003)
[9]  
Albig A.R., Neil J.R., Schiemann W.P., Fibulins 3 and 5 antagonize tumor angiogenesis in vivo, Cancer Res, 66, pp. 2621-2629, (2006)
[10]  
Albig A.R., Schiemann W.P., Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells, DNA Cell Biol, 23, pp. 367-379, (2004)